Molecular Epidemiology and Evolution of European Bat Lyssavirus 2.

McElhinney, Lorraine M; Marston, Denise A; Wise, Emma L; Freuling, Conrad M; Bourhy, Hervé; Zanoni, Reto Giacomo; Moldal, Torfinn; Kooi, Engbert A; Neubauer-Juric, Antonie; Nokireki, Tiina; Müller, Thomas; Fooks, Anthony R (2018). Molecular Epidemiology and Evolution of European Bat Lyssavirus 2. International journal of molecular sciences, 19(1) MDPI 10.3390/ijms19010156

[img]
Preview
Text
ijms-19-00156.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (2MB) | Preview

Bat rabies cases in Europe are mainly attributed to two lyssaviruses, namely European Bat Lyssavirus 1 (EBLV-1) and European Bat Lyssavirus 2 (EBLV-2). Prior to the death of a bat worker in Finland in 1985, very few bat rabies cases were reported. Enhanced surveillance in the two subsequent years (1986-1987) identified 263 cases (more than a fifth of all reported cases to date). Between 1977 and 2016, 1183 cases of bat rabies were reported, with the vast majority (>97%) being attributed to EBLV-1. In contrast, there have been only 39 suspected cases of EBLV-2, of which 34 have been confirmed by virus typing and presently restricted to just two bat species; and . The limited number of EBLV-2 cases in Europe prompted the establishment of a network of European reference laboratories to collate all available viruses and data. Despite the relatively low number of EBLV-2 cases, a large amount of anomalous data has been published in the scientific literature, which we have here reviewed and clarified. In this review, 29 EBLV-2 full genome sequences have been analysed to further our understanding of the diversity and molecular evolution of EBLV-2 in Europe. Analysis of the 29 complete EBLV-2 genome sequences clearly corroborated geographical relationships with all EBLV-2 sequences clustering at the country level irrespective of the gene studied. Further geographical clustering was also observed at a local level. There are high levels of homogeneity within the EBLV-2 species with nucleotide identities ranging from 95.5-100% and amino acid identities between 98.7% and 100%, despite the widespread distribution of the isolates both geographically and chronologically. The mean substitution rate for EBLV-2 across the five concatenated genes was 1.65 × 10, and evolutionary clock analysis confirms the slow evolution of EBLV-2 both between and within countries in Europe. This is further supported by the first detailed EBLV-2 intra-roost genomic analysis whereby a relatively high sequence homogeneity was found across the genomes of three EBLV-2 isolates obtained several years apart (2007, 2008, and 2014) from at the same site (Stokesay Castle, Shropshire, UK).

Item Type:

Journal Article (Review Article)

Division/Institute:

05 Veterinary Medicine > Research Foci > Host-Pathogen Interaction
05 Veterinary Medicine > Department of Infectious Diseases and Pathobiology (DIP) > Institute of Virology and Immunology
05 Veterinary Medicine > Department of Infectious Diseases and Pathobiology (DIP)

UniBE Contributor:

Zanoni, Reto Giacomo

Subjects:

600 Technology > 630 Agriculture
500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

1661-6596

Publisher:

MDPI

Language:

English

Submitter:

Pamela Schumacher

Date Deposited:

29 May 2019 13:57

Last Modified:

07 Aug 2024 15:45

Publisher DOI:

10.3390/ijms19010156

PubMed ID:

29303971

Uncontrolled Keywords:

EBLV-2 Europe Myotis bat epidemiology evolution genome

BORIS DOI:

10.7892/boris.127495

URI:

https://boris.unibe.ch/id/eprint/127495

Actions (login required)

Edit item Edit item
Provide Feedback